About Our Company

AI, Life Sciences & Enterprise SaaS Expertise

Founded October 2024. Building evidence-grounded clinical AI for regulated environments — a team of healthcare technologists, AI researchers, and enterprise operators who believe AI should be auditable, not just useful.

Our Mission

Fix Clinical Trial Recruitment

Clinical trial recruitment is broken. Nine of ten studies must extend timelines to hit enrollment targets. 11% of activated sites never recruit a single patient. The cost is staggering: $1.4M per day lost to delays across the industry. We're fixing this with AI that understands trials, sites, and patients.

90%
Of studies must double timelines to hit enrollment
11%
Of activated sites never enroll a single patient
$1.4M
Per day lost to trial delays across the industry
Our Team

Healthcare Technologists & Enterprise Leaders

Backgrounds spanning AI/ML research, clinical operations, pharmaceutical strategy, and B2B SaaS. A team built to understand trials, sites, and the CRO market.

Dr. Maksim Tsvetovat
Dr. Maksim Tsvetovat
CEO & Founder
check_circle PhD Computer Science, Carnegie Mellon
check_circle 20+ years AI/ML in healthcare
check_circle Former Director, Google Critical Infrastructure
check_circle Former Director, EPAM Healthcare AI
check_circle Senior Advisor, ARPA-H (2024-2025)
LinkedIn
Jaffrey Ali
Jaffrey Ali
VP Strategy
check_circle 20+ years B2B SaaS
check_circle Chief AI Officer, FranConnect
check_circle 5X revenue growth & 3 acquisitions
check_circle Product strategy, M&A, PLG expert
check_circle Rule of 40 track record
LinkedIn
Vladimir Vinogradov
Vladimir Vinogradov
CTO
check_circle 10+ years backend & Python
check_circle RAG/GraphRAG & AI pipelines
check_circle Cloud-native AWS/GCP
check_circle Scalable AI agents
check_circle Full-stack team lead
LinkedIn
Traction to Date

Real-World Validation

Four paying clients spanning CROs, wellness, and home-care operations. Operating across 38 U.S. states and 3 international markets. 200+ GB of clinical data processed and structured.

4
Paying Clients (CROs, Wellness, Home-Care)
38
U.S. States (Active Deployment)
3
International Markets
200+
GB Clinical Data Processed
Market Timing

Why Now?

Four converging forces have created a window for transformative change in clinical trial operations.

psychology
AI Maturity Arrived
Foundation models, retrieval-augmented generation, and agentic workflows have matured. The technology to extract meaning from unstructured clinical documents now exists at production scale.
policy
Regulatory Tailwinds
FDA's decentralized clinical trial (DCT) guidance and ICH E6(R3) are reshaping how trials are conducted. Digital-first workflows are no longer optional—they're required.
trending_up
Shift to Rare Disease & Oncology
The industry's pivot toward rare disease and oncology has fragmented patient populations and site specialization. Traditional site selection methods fail in this landscape.
merge
CRO Consolidation
The top 50 CROs now control 80% of the clinical trials market. This consolidation creates a concentrated buyer base ideal for enterprise go-to-market strategies.

Let's Transform Clinical Trials Together

See how Research Lambda is helping sponsors and CROs solve the recruitment challenge with AI.

arrow_forward Book a Demo layers View Our Platform